About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
Investor Relations
Press Releases
[+view all]
10.19.2023
ARCA biopharma Announces Third Quarter 2023 Financial Results
07.21.2023
ARCA biopharma Announces Second Quarter 2023 Financial Results and Provides Corporate Update
04.25.2023
ARCA biopharma Announces First Quarter 2023 Financial Results
About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
Investor Relations
Press Releases
[+view all]
10.19.2023
ARCA biopharma Announces Third Quarter 2023 Financial Results
07.21.2023
ARCA biopharma Announces Second Quarter 2023 Financial Results and Provides Corporate Update
04.25.2023
ARCA biopharma Announces First Quarter 2023 Financial Results
Presentations
[GO]
Annual Financial Reports
[GO]
SEC Filings
[GO]
Frequently Asked Questions
[GO]
Corporate Governance
Committee Charters
Audit Committee
Compensation Committee
Nominating & Governance Committee
Governance Documents
Board of Directors Corporate Governance Principles
ARCA biopharma, Inc. Code of Business Conduct and Ethics
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
Contact the Board
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Linda Grais, M.D.
Robert E. Conway
Dan Mitchell
Anders Hove, M.D.